Oracle earnings: Positioning for possible upside with options

Oracle earnings: Positioning for possible upside with options

Saxo Be Invested
APAC Research

Key points:

  • Oracle reports earnings on March 10: Analysts expect Oracle's Q3 FY2025 earnings to show an 8% YoY revenue growth to $14.4 billion and a 6% increase in EPS to $1.49. Key factors to watch include the transition of customers to cloud and AI services, AI monetization, and updates on the Stargate AI initiative.
  • Guidance for Q4 FY25 will be key: Investors will be looking for guidance on AI services growth in Q4 as that is key to meet full year guidance of double-digit revenue growth.
  • Synthetic long strategy: For investors looking to gain exposure to Oracle's potential upside without buying the stock outright, a synthetic long position can be an effective strategy. This involves buying a $155 call and selling a $155 put with the same expiration, allowing for upside participation with a lower initial investment.

Oracle (ORCL) is set to report its fiscal Q3 2025 earnings on Monday, March 10, 2025 after market close. The stock has declined 7% year-to-date (YTD) but remains up approximately 35% over the past 12 months. Broader tech sector weakness, competitive concerns following China’s launch of DeepSeek and other AI models, and tariff threats have pressured valuations ahead of the report.

Market expectations for Q3 earnings

Analysts have set high expectations for Oracle’s Q3 results:

  • Revenue growth: +8% YoY to $14.4 billion
  • EPS growth: +5.7% YoY to $1.49 (vs. +9.7% in Q2)
  • Average implied 1-day move: 9%

Key factors to watch

Customer transition to cloud and AI services

Oracle continues to shift its enterprise customer base from legacy database software to cloud-based and AI-driven solutions. As a result, Oracle’s cloud growth is catching up as a viable alternative to the three hyperscalers – Amazon Web Services, Microsoft and Google. However, Oracle has only mentioned the new, larger customer deals briefly earlier. Investors may be looking for more substantial updates on customer adoption rates and contract wins, and any such details could drive positive momentum in the stock.

AI monetization and infrastructure growth

A primary focal point will be Oracle’s ability to meet expectations for Infrastructure-as-a-Service (IaaS) revenue growth, as this is key for Oracle to achieve its double-digit revenue growth guidance for full year. Analysts expect 56% IaaS revenue growth in Q4 on a constant currency basis. This segment is a key growth driver, and any commentary around AI infrastructure monetization strategies could significantly influence the stock’s post-earnings reaction.

Update on Stargate AI initiative

Oracle’s involvement in the up-to-$500 billion AI infrastructure project, Stargate, a JV with SoftBank and OpenAI, could be a major talking point. Any new details regarding its scale, execution timeline, and Oracle’s financial commitment may outweigh other earnings details in the eyes of investors.

Capital expenditures and free cash flow outlook

Oracle is expected to increase capital expenditures by nearly 30% this fiscal year to support its cloud and AI ambitions. This could be a key focus, especially after DeepSeek’s claims to bring AI models at a fraction of the cost that US tech players have been spending. While this investment is necessary for long-term growth, it may pressure short-term free cash flow. Investors will be looking for guidance on when spending may taper off and how free cash flow could rebound in later years.

Foreign exchange headwinds

Over 40% of Oracle’s revenue comes from international markets. A strong U.S. dollar could negatively impact reported earnings by reducing the dollar value of foreign sales. Investors will be closely watching whether currency fluctuations present a meaningful drag on results, but these are likely to be considered a tactical interference with US dollar on a bearish trend now easing concerns about its impact on earnings in Q4.


Using a synthetic long for bullish exposure

For investors looking to gain exposure to Oracle’s potential upside after earnings without buying the stock outright, a synthetic long position can be an effective strategy.

Synthetic long setup (Example strategy at $155 current price)

  • Buy the $155 call expiring in 1-2 months
  • Sell the $155 put with the same expiration
  • Objective: Replicate stock ownership with less capital upfront

Outcome Scenarios

  1. Stock rises above $155 (profitable trade): If Oracle rises above $155, the call option gains value while the short put expires worthless. This mimics the effect of holding the stock and allows for upside participation with a lower initial investment.
  2. Stock stays around $155 (minimal impact): If Oracle remains near $155 by expiration, the position remains largely unchanged, with minor gains or losses depending on time decay and implied volatility changes.
  3. Stock declines below $155 (potential obligation to buy): If Oracle drops, the call option loses value while the short put could result in the obligation to buy shares at $155. This is similar to stock ownership, meaning the trader should be willing to take on the stock if assigned.
Source: Saxo

Why use a synthetic long?

  • Lower capital requirement: Unlike buying shares, this strategy requires less capital while still gaining upside exposure.
  • Leverage benefits: Allows traders to benefit from potential stock gains without tying up large amounts of capital.
  • Flexibility: Can be adjusted or closed before expiration if Oracle's earnings reaction is different than expected.

Final thoughts

Oracle’s Q3 earnings will be closely watched for AI-related developments, cloud growth, and capex guidance. While risks such as foreign exchange pressures and valuation concerns persist, strong execution on key growth initiatives could drive a significant stock reaction. A synthetic long strategy provides a way to gain exposure to Oracle’s upside while using less capital than traditional stock ownership, making it an effective approach for bullish investors.

Quarterly Outlook

01 /

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

  • Equity Outlook: Will lower rates lift all boats in equities?

    Quarterly Outlook

    Equity Outlook: Will lower rates lift all boats in equities?

    Peter Garnry

    Chief Investment Strategist

    After a period of historically high equity index concentration driven by the 'Magnificent Seven' sto...
  • Commodity Outlook: Gold and silver continue to shine bright

    Quarterly Outlook

    Commodity Outlook: Gold and silver continue to shine bright

    Ole Hansen

    Head of Commodity Strategy

  • Macro Outlook: The US rate cut cycle has begun

    Quarterly Outlook

    Macro Outlook: The US rate cut cycle has begun

    Peter Garnry

    Chief Investment Strategist

    The Fed started the US rate cut cycle in Q3 and in this macro outlook we will explore how the rate c...
  • FX Outlook: USD in limbo amid political and policy jitters

    Quarterly Outlook

    FX Outlook: USD in limbo amid political and policy jitters

    Charu Chanana

    Chief Investment Strategist

    As we enter the final quarter of 2024, currency markets are set for heightened turbulence due to US ...

Disclaimer

The Saxo Group entities each provide execution-only service, and access to analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Inspiration Disclaimer and (v) Notices applying to Trade Inspiration, Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular, no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Trading in financial instruments carries risk, and may not be suitable for you. Past performance is not indicative of future performance. Please read our disclaimers:
Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/en-sg/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Markets or its affiliates.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Select region

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.